Safety and Health at Work

Occupational Safety and Health Research Institute, Korea Occupational Safety and Health Agency (산업안전보건연구원)
권호 표지
DOI QR코드

DOI QR Code

Occupational Exposure to Antineoplastic Drugs: Identification of Job Categories Potentially Exposed throughout the Hospital Medication System

  • Received : 2011.04.01
  • Accepted : 2011.07.11
  • Published : 2011.09.30
Download PDF
⟨ Previous Next ⟩

Abstract

Objectives: Studies examining healthcare workers' exposure to antineoplastic drugs have focused on the drug preparation or drug administration areas. However, such an approach has probably underestimated the overall exposure risk as the drugs need to be delivered to the facility, transported internally and then disposed. The objective of this study is to determine whether drug contamination occurs throughout a facility and, simultaneously, to identify those job categories that are potentially exposed. Methods: This was a multi-site study based in Vancouver, British Columbia. Interviews were conducted to determine the departments where the drugs travel. Subsequent site observations were performed to ascertain those surfaces which frequently came into contact with antineoplastic drugs and to determine the job categories which are likely to contact these surfaces. Wipe samples were collected to quantify surface contamination. Results: Surface contamination was found in all six stages of the hospital medication system. Job categories consistently found to be at risk of exposure were nurses, pharmacists, pharmacy technicians, and pharmacy receivers. Up to 11 job categories per site may be at risk of exposure at some point during the hospital medication system. Conclusion: We found drug contamination on select surfaces at every stage of the medication system, which indicates the existence of an exposure potential throughout the facility. Our results suggest that a broader range of workers are potentially exposed than has been previously examined. These results will allow us to develop a more inclusive exposure assessment encompassing all healthcare workers that are at risk throughout the hospital medication system.

Keywords

References

  1. Sessink PJ, Bos RP. Drugs hazardous to healthcare workers. Evaluation of methods for monitoring occupational exposure to cytostatic drugs. Drug Saf 1999;20:347-59. https://doi.org/10.2165/00002018-199920040-00004
  2. Sessink PJ, Boer KA, Scheefhals AP, Anzion RB, Bos RP. Occupational exposure to antineoplastic agents at several departments in a hospital. Environmental contamination and excretion of cyclophosphamide and ifosfamide in urine of exposed workers. Int Arch Occup Environ Health 1992;64:105-12. https://doi.org/10.1007/BF00381477
  3. Connor TH, Anderson RW, Sessink PJ, Broadfield L, Power LA. Surface contamination with antineoplastic agents in six cancer treatment centers in Canada and the United States. Am J Health Syst Pharm 1999;56:1427-32.
  4. Siderov J, Kirsa S, McLauchlan R. Surface contamination of cytotoxic chemotherapy preparation areas in Australian Hospital Pharmacy Departments. J Pharm Pract Res 2009;39:117-21. https://doi.org/10.1002/j.2055-2335.2009.tb00434.x
  5. Schmaus G, Schierl R, Funck S. Monitoring surface contamination by antineoplastic drugs using gas chromatographymass spectrometry and voltammetry. Am J Health Syst Pharm 2002;59:956-61.
  6. Acampora A, Castiglia L, Miraglia N, Pieri M, Soave C, Liotti F, Sannolo N. A case study: surface contamination of cyclophosphamide due to working practices and cleaning procedures in two Italian hospitals. Ann Occup Hyg 2005;49:611-8. https://doi.org/10.1093/annhyg/mei029
  7. Cavallo D, Ursini CL, Perniconi B, Francesco AD, Giglio M, Rubino FM, Marinaccio A, Iavicoli S. Evaluation of genotoxic effects induced by exposure to antineoplastic drugs in lymphocytes and exfoliated buccal cells of oncology nurses and pharmacy employees. Mutat Res 2005;587:45-51. https://doi.org/10.1016/j.mrgentox.2005.07.008
  8. Touzin K, Bussieres JF, Langlois E, Lefebvre M. Evaluation of surface contamination in a hospital hematology--oncology pharmacy. J Oncol Pharm Pract 2009;15:53-61. https://doi.org/10.1177/1078155208096904
  9. Connor TH, Sessink PJ, Harrison BR, Pretty JR, Peters BG, Alfaro RM, Bilos A, Beckmann G, Bing MR, Anderson LM, Dechristoforo R. Surface contamination of chemotherapy drug vials and evaluation of new vial-cleaning techniques: results of three studies. Am J Health Syst Pharm 2005;62:475-84.
  10. Mason HJ, Morton J, Garfitt SJ, Iqbal S, Jones K. Cytotoxic drug contamination on the outside of vials delivered to a hospital pharmacy. Ann Occup Hyg 2003;47:681-5. https://doi.org/10.1093/annhyg/meg078
  11. Hedmer M, Georgiadi A, Bremberg ER, Jönsson BA, Eksborg S. Surface contamination of cyclophosphamide packaging and surface contamination with antineoplastic drugs in a hospital pharmacy in Sweden. Ann Occup Hyg 2005;49:629-37. https://doi.org/10.1093/annhyg/mei042
  12. Zeedijk M, Greijdanus B, Steenstra FB, Uges DR. Monitoring exposure of cytostatics on the hospital ward. Eur J Hosp Pharm Sci 2005;11:18-22.
  13. Shih TS, Lu PY, Chen CH, Soo JC, Tsai CL, Tsai PJ. Exposure profiles and source identifications for workers exposed to crystalline silica during a municipal waste incinerator relining period. J Hazard Mater 2008;154:469-75. https://doi.org/10.1016/j.jhazmat.2007.10.047
  14. Chu WC, Hon CY, Danyluk Q, Chua PP, Astrakianakis G. Pilot assessment of the antineoplastic drug contamination levels in British Columbian hospitals pre- and post-cleaning. J Oncol Pharm Pract 2011. [Epub ahead of print]
  15. Fransman W, Vermeulen R, Kromhout H. Dermal exposure to cyclophosphamide in hospitals during preparation, nursing and cleaning activities. Int Arch Occup Environ Health 2005;78:403-12. https://doi.org/10.1007/s00420-004-0595-1
  16. Kromhout H, Hoek F, Uitterhoeve R, Huijbers R, Overmars RF, Anzion R, Vermeulen R. Postulating a dermal pathway for exposure to anti-neoplastic drugs among hospital workers. Applying a conceptual model to the results of three workplace surveys. Ann Occup Hyg 2000;44:551-60. https://doi.org/10.1016/S0003-4878(00)00050-8
  17. Sessink PJ, Van de Kerkhof MC, Anzion RB, Noordhoek J, Bos RP. Environmental contamination and assessment of exposure to antineoplastic agents by determination of cyclophosphamide in urine of exposed pharmacy technicians: is skin absorption an important exposure route? Arch Environ Health 1994;49:165-9. https://doi.org/10.1080/00039896.1994.9940377
  18. National Institute for Occupational Safety and Health. NIOSH Alert: Preventing Occupational Exposures to Antineoplastic and Other Hazardous Drugs in Health Care Settings. Cincinatti (OH): US Department of Health and Human Services, Public Health Service, Centers for Disease Control and Prevention; 2004. DHHS (NIOSH) Publication No. 2004-165.
  19. Sorsa M, Hameila M, Jarviluoma E. Handling anticancer drugs. Ann NY Acad Sci 2006;1076:628-34. https://doi.org/10.1196/annals.1371.008
  20. Occupational Exposure Estimates - Antineoplastic Agents [Internet]. Vancouver (BC): CAREX Canada. 2011 [cited 30 May 2011]. Available from: http://www.carexcanada.ca/en/antineoplastic_agents/occupational_exposure_estimates/phase_2/.

Cited by

  1. Antineoplastic Drug Contamination of Surfaces Throughout the Hospital Medication System in Canadian Hospitals vol.10, pp.7, 2013, https://doi.org/10.1080/15459624.2013.789743
  2. Antineoplastic drugs contamination of workplace surfaces in two Portuguese hospitals vol.186, pp.11, 2014, https://doi.org/10.1007/s10661-014-3969-1
  3. Preventing the contamination of hospital personnel by cytotoxic agents: evaluation and training of the para-professional healthcare workers in oncology units vol.24, pp.3, 2014, https://doi.org/10.1111/ecc.12249
  4. More than just crushing: a prospective pre-post intervention study to reduce drug preparation errors in patients with feeding tubes vol.40, pp.2, 2015, https://doi.org/10.1111/jcpt.12250
  5. A surface wipe sampling and LC–MS/MS method for the simultaneous detection of six antineoplastic drugs commonly handled by healthcare workers vol.407, pp.23, 2015, https://doi.org/10.1007/s00216-015-8868-y
  6. Antineoplastic drug contamination in the urine of Canadian healthcare workers vol.88, pp.7, 2015, https://doi.org/10.1007/s00420-015-1026-1